Can Fite Biopharma ADR Representing 300 Ord Shs (CANF) has risen Wednesday morning, with the stock adding 3.27% in pre-market trading to 2.21. CANF's short-term technical score of 38 indicates that the stock has traded less bullishly over the last month than 62% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, Can Fite Biopharma ADR Representing 300 Ord Shs ranks higher than 57% of stocks. Can Fite Biopharma ADR Representing 300 Ord Shs has risen 3.88% over the past month, closing at $1.91 on October 25. During this period of time, the stock fell as low as $1.90 and as high as $2.19. CANF has an average analyst recommendation of Strong Buy. The company has an average price target of $12.00.